Optimal therapy for adults with langerhans cell histiocytosis bone lesions

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Cantu, Maria A ^a   Lupo, Philip J ^b   Bilgi, Mrinalini ^a   Hicks, M John ^a   Allen, Carl E ^a   McClain, Kenneth L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; CYTARABINE; PREDNISONE; STEROID; VINBLASTINE;

ADULT; ADULTHOOD; AGED; ARTICLE; BONE LESION; CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; CURETTAGE; CYTOPENIA; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; HISTIOCYTOSIS X; HUMAN; JAW DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROPATHY; RADIOTHERAPY; SKULL INJURY; SPINE INJURY; STEROID THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; BONE DISEASES; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINBLASTINE; YOUNG ADULT;

EID: 84865048852     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043257     Document Type: Article

References (22)

1. Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, et al. (2010) Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol 184: 4557-4567.
2. McClain KL and Allen CE (2010) Inflammatory and Malignant Histiocytosis. In: Kenneth Kaushansky, editors. Williams Hematology. New York: McGraw Hill Medical. 1047-1064.
3. Islinger RB, Kuklo TR, Owens BD, Horan PJ, Choma TJ, et al. (2000) Langerhans' cell histiocytosis in patients older than 21 years. Clin Orthop Relat Res 231-235.
4. Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, et al. (2003) Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 39: 2341-2348.
5. Gotz G, Fichter J, (2004) Langerhans'-cell histiocytosis in 58 adults. Eur J Med Res 9: 510-514.
6. Baumgartner I, von HA, Baumert B, Luetolf U, Follath F, (1997) Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol 28: 9-14.
7. Olschewski T, Seegenschmiedt MH, (2006) Radiotherapy of Langerhans' Cell Histiocytosis: Results and Implications of a National Patterns-of-Care Study. Strahlenther Onkol 182: 629-634.
8. Atalar B, Miller RC, Dincbas FO, Geismar JH, Micke O, et al. (2010) Adult langerhans cell histiocytosis of bones: a rare cancer network study. Acta Orthop Belg 76: 663-668.
9. Malpas JS, Norton AJ, (1996) Langerhans cell histiocytosis in the adult. Med Pediatr Oncol 27: 540-546.
10. Weitzman S, McClain KL, Arceci R (2005) Salvage Therapies for Langerhans Cell Histiocytosis. In: Egeler RM, Weitzman S, editors. Histiocytic Disorders of Children and Adults. Cambridge: Cambridge Press. 254-271.
11. Matsuki E, Tsukada Y, Nakaya A, Yokoyama K, Okamoto S, (2011) Successful treatment of adult onset Langerhans cell histiocytosis with multi-drug combination therapy. Intern Med 50: 909-914.
12. Ardekian L, Peled M, Rosen D, Rachmiel A, Abu el-Naaj I, et al. (1999) Clinical and radiographic features of eosinophilic granuloma in the jaws: review of 41 lesions treated by surgery and low-dose radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87: 238-242.
13. Huang W, Yang X, Cao D, Xiao J, Yang M, et al. (2010) Eosinophilic granuloma of spine in adults: a report of 30 cases and outcome. Acta Neurochir (Wien) 152: 1129-1137.
14. Derenzini E, Fina MP, Stefoni V, Pellegrini C, Venturini F, et al. (2010) MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol 21: 1173-1178.
15. Sivendran S, Harvey H, Lipton A, Drabick J, (2011) Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series. Int J Hematol 93: 782-786.
16. Gadner H, Grois N, Potschger U, Minkov M, Arico M, et al. (2008) Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 111: 2556-2562.
17. Weitzman S, Braier J, Donadieu J, Egeler RM, Grois N, et al. (2009) 2′-Chlorodeoxyadenosine (2-CdA) as Salvage Therapy for Langerhans Cell Histiocytosis (LCH). Results of the LCH-S-98 Protocol of the Histiocyte Society. Pediatr Blood Cancer 2009 53: 1271-1276.
18. Egeler RM, de KJ, Voute PA, (1993) Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol 21: 265-270.
19. Slater JM, Swarm OJ (1980) Eosinophilic granuloma of bone. Med Pediatr Oncol 8: 151-164.
20. Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, et al. (2001) Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol 37: 108-114.
21. Grois N, Potschger U, Prosch H, Minkov M, Arico M, et al. (2006) Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer 46: 228-233.
22. Mittheisz E, Seidl R, Prayer D, Waldenmair M, Neophytou B, et al. (2007) Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatr Blood Cancer 48: 50-56.